SCHEMBL501137

SCHEMBL501137

O=C1c2ccccc2OC(O)C1c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.49
KDR P35968 1/20 0.49
CYP19A1 P11511 4/20 0.47
ADORA3 P0DMS8 3/20 0.47
MAOB P27338 3/20 0.47
AR P10275 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 1/20 0.47
MAPT P10636 3/20 0.42
CYP3A4 P08684 2/20 0.42
MAPK1 P28482 2/20 0.42
ESR1 P03372 2/20 0.42
ESR2 Q92731 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
HTR2B P41595 1/20 0.41
STK17B O94768 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29963529 1.00 RET (0.49) RETKDRCYP19A1ADORA3MAOB
SCHEMBL16376660 0.82 ESR1 (0.55) RETKDRCYP19A1ADORA3MAOB
SCHEMBL21371327 0.79 CYP19A1 (0.47) RETKDRCYP19A1ADORA3MAOB
SCHEMBL18885280 0.79 CYP19A1 (0.47) RETKDRCYP19A1ADORA3MAOB
SCHEMBL3965026 0.79 CYP19A1 (0.47) RETKDRCYP19A1ADORA3MAOB
SCHEMBL2838579 0.78 RET (0.58) RETKDRCYP19A1ADORA3MAOB
SCHEMBL24115843 0.77 RET (0.77) RETKDRCYP19A1ADORA3MAOB
SCHEMBL29843330 0.77 RET (0.77) RETKDRCYP19A1ADORA3MAOB
SCHEMBL3362960 0.77 RET (0.77) RETKDRCYP19A1ADORA3MAOB
SCHEMBL29367518 0.77 RET (0.77) RETKDRCYP19A1ADORA3MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106146-B2 Therapeutic polymers and methods of generation MEDTRONIC, INC. (US) 2012-01-31 US claimed
US-20110082266-A1 THERAPEUTIC POLYMERS AND METHODS OF GENERATION MEDTRONIC, INC. 2011-04-07 US claimed
US-20070050865-A1 Polynucleotide encoding 2-hydorxyisoflavanone dehydratase and application of the same NIHON UNIVERSITY (JP) 2007-03-01 US claimed
EP-0710234-A1 ISOFLAVONE DERIVATIVES CHINOIN LTD. (HU) 1996-05-08 EP claimed
WO-1995003293-A1 ISOFLAVONE DERIVATIVES CHINOIN LTD. (HU) 1995-02-02 WO claimed
EP-3868360-B1 COMPOSITION FOR INHIBITING ACTIVATION OF MINERALCORTICOID RECEPTOR AMOREPACIFIC CORP (KR) 2025-12-10 EP disclosed
CN-115109809-B Midecarin is a biosynthesis method of (2) 南京中医药大学 2025-03-04 CN disclosed
US-20240263203-A1 RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF TETRAKETIDE DERIVATIVES IPTECTOR ASSETS APS (DK) 2024-08-08 US disclosed
WO-2023230574-A1 ENGINEERED PHENYLALANINE AMMONIA LYASE AND TYROSINE AMMONIA LYASE ENZYMES FOR PRODUCING AROMATIC COMPOUNDS GINKGO BIOWORKS, INC. (US) 2023-11-30 WO disclosed
CN-115109809-A Biosynthesis method of santalin 南京中医药大学 2022-09-27 CN disclosed
US-9139853-B2 Organisms for the production of cyclohexanone GENOMATICA, INC. (US) 2015-09-22 US disclosed
EP-2885400-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS Celexion, LLC (US) 2015-06-24 EP disclosed
WO-2000071736-A1 ISOFLAVONOID METHYLATION ENZYME THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) 2000-11-30 WO disclosed
WO-2000053771-A1 GENETIC MANIPULATION OF ISOFLAVONOIDS THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) 2000-09-14 WO disclosed
WO-2000044909-A1 NUCLEIC ACID SEQUENCES ENCODING ISOFLAVONE SYNTHASE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2000-08-03 WO disclosed
EP-0710234-A1 ISOFLAVONE DERIVATIVES CHINOIN LTD. (HU) 1996-05-08 EP disclosed
WO-1995003293-A1 ISOFLAVONE DERIVATIVES CHINOIN LTD. (HU) 1995-02-02 WO disclosed
US-4166862-A WEIGHT-GAIN PROMOTERS CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1979-09-04 US disclosed
US-4163746-A ANABOLIC, 5-METHYL-7-ALKOXYISOFLAVONES CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1979-08-07 US disclosed
US-3949085-A Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same CHINOIN GYOGYSZER-ES VEGYESZETI TERMAKEK GYARA RT (HU) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082266-A1 THERAPEUTIC POLYMERS AND METHODS OF GENERATION OGFR, OAT, ALK RET 815/4885KDR 364/4885CYP19A1 3801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.